Educational Activities

Certified Activity
Non-certified Activity
Resource
Patient Education
Expired Activity

1-6 of 318 Activities

Title
Availability
Format
Credits
Launch Date
Buttons
Buttons

Livestream: Shedding Light on Bowel Urgency: Presenting the Latest Data and Initiating Conversations in Crohn’s Disease Management

In this CMEO Outfitters livestream symposium, expert faculty will discuss recognizing the frequency of bowel urgency in patients with CD and the impact to patient QoL, incorporating assessments for bowel urgency as part of thorough symptom evaluation for patients with CD, and engaging patients in open communication about their bowel urgency as part of shared decision-making in order to improve clinical outcomes.

1.5
05/20/2024 at 6:15 am EST

Angelina E. Collins, MSN, ANP-BC

Angelina E. Collins, MSN, ANP-BC

Marla Dubinsky, MD

Marla Dubinsky, MD

Moderator

Millie D. Long

Millie D. Long, MD, MPH, is board certified in internal medicine, preventive medicine, and gastroenterology. Dr. Long received her medical degree from University of Virginia in 2002

Millie D. Long

Millie D. Long, MD, MPH, is board certified in internal medicine, preventive medicine, and gastroenterology. Dr. Long received her medical degree from University of Virginia in 2002. She then completed residency in internal medicine and a chief residency at University of Alabama at Birmingham. She completed fellowships in gastroenterology and hepatology, preventive medicine, and inflammatory bowel disease, all at University of North Carolina. She is currently Professor of Medicine in the Department of Medicine and Director of the Gastroenterology and Hepatology Fellowship Program at University of North Carolina at Chapel Hill.

Dr. Long’s clinical practice is at the UNC Multidisciplinary Inflammatory Bowel Diseases (IBD) Center. Her research interests include prevention of complications of IBD, women’s health, and clinical epidemiology. Dr. Long has contributed to over 200 peer-reviewed publications, book chapters, and review articles and to the medical literature. She is the current co-Editor in Chief of the American Journal of Gastroenterology. She also serves as an invited reviewer for journals such as Inflammatory Bowel Diseases and Gastroenterology.

Dr. Long is a fellow of the American College of Gastroenterology, where she serves on the Board of Trustees. She is also a fellow of the American Gastroenterological Association and the Crohn’s and Colitis Foundation, where she co-chairs the Clinical Research Alliance.

Buttons
Live
Symposium
1.5
05/19/2024 at 6:30 pm EST

Livestream: Visualizing the Future: Advances in IL-23-Targeted Therapies in the Treatment of IBD

In this CME Outfitters livestream symposium, expert faculty will review the role of the IL-23/Th-17 pathway in the pathogenesis of IBD and utilize animated 3-D models to illustrate differences in agents in the anti-IL-23 class that may have potential therapeutic implications. Learners will be guided through an evaluation of the potential clinical implications of CD64 receptor binding by anti-IL-23 mAbs in IBD treatment, as well as the clinical evidence supporting the benefits of these IBD treatment features.

1.5
05/19/2024 at 6:30 pm EST

Angelina E. Collins, MSN, ANP-BC

Angelina E. Collins, MSN, ANP-BC

Edward V. Loftus, Jr., MD

Edward V. Loftus, Jr., MD

Jessica R. Allegretti, MD, MPH, FACG, AGAF

Jessica R. Allegretti, MD, MPH, FACG, AGAF

Miguel Regueiro, MD, AGAF, FACG, FACP

Miguel Regueiro

Miguel Regueiro earned his bachelor's degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School's Beth Israel Hospital.
Miguel Regueiro, MD, AGAF, FACG, FACP

Miguel Regueiro

Moderator

Miguel Regueiro earned his bachelor’s degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital.

Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases.

Dr. Regueiro is currently the Chair of the Department of Gastroenterology and Hepatology and Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as Medical Co- Chair of Digestive Disease and Surgical Institute Research Governance committee and is Professor of Medicine at the Lerner College of Medicine, Cleveland Clinic.

Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. Dr. Regueiro is investigating alternative models of care in population-based health that integrates patients, payers, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs.

Buttons

Life Disrupted: Role of Advanced Practice Providers in Guiding Patients with Crohn’s Disease Through the Challenges of Bowel Urgency

Up to 80% of patients with Crohn’s disease (CD) report some degree of bowel urgency, a symptom that not only significantly adds to their overall emotional and social burden but can be an indicator of uncontrolled bowel inflammation. Unfortunately, bowel urgency is largely underrecognized by health care professionals (HCPs) caring for patients with CD. Nurse practitioners (NPs) and physician associates (PAs) in the gastroenterology field are positioned to initiate screening for bowel urgency as part of thorough symptom evaluation while establishing open communication with patients and implementing shared decision-making.

In this CME Outfitters live webcast, leading clinical experts will help prepare learners to discuss, assess, and address bowel urgency in patients with CD, and will provide insight into the efficacy and safety of new and emerging therapies. The webcast will also include videos capturing the patient journey and first-hand experiences.

1
05/01/2024 at 6:30 pm EST

Amar Naik, MD

Amar Naik, MD

Susan T. Wolgamott, DNP, FNP-C, CTN-B

Susan T. Wolgamott, DNP, FNP-C, CTN-B

Kimberly Orleck, PA-C

Kimberly Orleck, PA-C

Buttons
Live
Webcast
1
04/03/2024 at 6:30 pm EST

Life Reclaimed: APPs Guiding Patients with Ulcerative Colitis Through Symptoms of Bowel Urgency

In this CME Outfitters live webcast, leading clinical experts will help prepare learners to discuss, assess, and address bowel urgency in patients with UC, and will provide insight into the effects of new and emerging therapies.

1
04/03/2024 at 6:30 pm EST

Kimberly Kearns, MS, APRN, ANP-BC

Kimberly Kearns, MS, APRN, ANP-BC

Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE

Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE

Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP

Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP

Moderator

Buttons
On-Demand
Podcast
.5
03/28/2024

A Wild-Type of Approach in the First-line Treatment of HRD-Positive Advanced Ovarian Cancer

Data from recent clinical trials for first-line combination options using immunotherapies for ovarian cancer (OC) can be challenging for clinicians with no experience selecting patients for combinatorial treatment approaches or using combination therapies for their patients.  During this podcast, Drs. Richard Penson and Ramez Eskander will educate clinicians on the use of immune checkpoint inhibitors for the treatment of OC and the use of biomarker analyses to optimize patient selection.

.5
03/28/2024

Ramez N. Eskander, MD

Ramez N. Eskander, MD

Richard T. Penson

Richard T. Penson, MD, MRCP, is a Medical Oncologist at Massachusetts General Hospital, and Associate Professor of Medicine at Harvard Medical School. A key opinion leader, Dr. Penson was a longstanding member of the Gynecologic Oncology Group Ovarian and Quality of Life Committees and now serves on the Foundation’s Investigator Council.

Richard T. Penson

(Moderator)

Richard T. Penson, MD, MRCP, is a Medical Oncologist at Massachusetts General Hospital, and Associate Professor of Medicine at Harvard Medical School. A key opinion leader, Dr. Penson was a longstanding member of the Gynecologic Oncology Group Ovarian and Quality of Life Committees and now serves on the Foundation’s Investigator Council. He is the national Principal Investigator (PI) of the olaparib registration trial (SOLO-2) and the international PI of SOLO3, and the OVAL trial. He has taught on Harvard’s Practice of Medicine Course, the Bigelow General Medical Service at Massachusetts General Hospital, and is one of the Chairs of the Institutional Review Board of Dana-Farber Harvard Cancer Center.

Buttons
On-Demand
Webinar
1
03/28/2024

Findings from an Educational Initiative Addressing Racial Disparities and Bias in Health Care

Racism has historically, systemically, and continuously developed and fueled discriminatory practices and rhetoric against racial and ethnic underserved individuals in the United States. Those practices remain embedded in society and institutions, including the healthcare system. Given the long-standing history and ongoing impact of systemic racism, health disparities and inequities result in barriers to care and undermine patient health outcomes. As such, it is imperative to address racial disparities and inequities in health care. It is essential to understand the impact of historical racism, latest evidence on health inequities, and action steps health care professionals (HCPs) should take to pave the way for equitable care guided by cultural humility that will lead to improved health outcomes.
The CME Outfitters Diversity, Equity, and Inclusion (DE&I) phase 1 initiative focused on six key therapeutic areas: maternal health, cardiovascular care, pain management, oral health, dermatologic health/melanoma, and elective surgery. Each of these areas face significant health inequities, leading to increased morbidity and mortality rates among  underserved populations. This digital monograph illustrates the impact of the educational initiative on HCP knowledge and competence as well as patient outcomes.

1
03/28/2024

Monica E. Peek

Monica Peek, MD, MPH, MSc is an Ellen H. Block Professor of Health Justice in the Department of Medicine.

Monica E. Peek

Monica Peek, MD, MPH, MSc is an Ellen H. Block Professor of Health Justice in the Department of Medicine. She is also the Associate Director, Chicago Center for Diabetes Translation Research, and Director of Research, MacLean Center for Clinical Medical Ethics. She is a practicing internist, medical educator, and clinician investigator. Her research pursues health equity and social justice, with a focus on promoting equitable doctor/patient relationships among racial minorities, integrating the medical and social needs of patients, and addressing health care discrimination and structural racism impacting health outcomes (e.g., diabetes, COVID-19). Dr. Peek has authored more than 200 peer-reviewed publications and abstracts on health care disparities, diversity, and bias; has been the principal investigator of multiple grants to address health disparities; and has been invited to speak at numerous local and national medical meetings.